Company:  INSPIREMD, INC. (NSPR)
Form Type:  10-K
Filing Date:  9/17/2013 
CIK:  0001433607 
Address:  321 COLUMBUS AVENUE 
City, State, Zip:  BOSTON, Massachusetts 02116 
Telephone:  (857) 453-6553 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$0.28  
Change: 
0.072 (34.62%)  
Trade Time: 
Aug 04  
Market Cap: 
$21.80M
Trade NSPR now with 

Description of Business
We are a medical device company focusing on the development and commercialization of our proprietary MicroNet stent platform technology for the treatment of complex coronary and vascular disease. A stent is an expandable "scaffold-like" device, usually constructed of a metallic material, that is inserted into an artery to expand the inside passage and improve blood flow. Our MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Our initial MGuard coronary products (MGuard and MGuard Prime Embolic Protection Stent (EPS)) are marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery).
Register and access this filing in:     
  FORM 10-K
    PART I
      Item 1. Business.
      Item 1A. Risk Factors.
      Item 1B. Unresolved Staff Comments.
      Item 2. Properties.
      Item 3. Legal Proceedings.
      Item 4. Mine Safety Disclosures.
    PART II
      Item 5. Market for Registrant's Common Equity, ...
      Item 6. Selected Financial Data.
      Item 7. Management's Discussion and Analysis of Financial ...
        Results of Operations
        Liquidity and Capital Resources
      Item 7A. Quantitative and Qualitative Disclosures About ...
      Item 8. Financial Statements and Supplementary Data.
      Item 9. Changes in and Disagreements with Accountants on ...
      Item 9A. Controls and Procedures.
      Item 9B. Other Information.
    PART III
      Item 10. Directors, Executive Officers and Corporate Governance.
        NAME AND TITLE
      Item 11. Executive Compensation.
        COMPENSATION TABLE
        OPTIONS
        OPTIONS AGGREGATE
      Item 12. Security Ownership of Certain Beneficial Owners and ...
        BENEFICIAL OWNERS
      Item 13. Certain Relationships and Related Transactions, and ...
      Item 14. Principal Accountant Fees and Services.
    PART IV
      Item 15. Exhibits and Financial Statement Schedules.
    Notes to Consolidated Financial Statements
    SIGNATURES
    Report of Independent Registered Public Accounting Firm
    BALANCE SHEET
    INCOME STATEMENT
    STOCKHOLDERS EQUITY
    CASH FLOW
    INCOME STATEMENT
    NOTE 13 - SUBSEQUENT EVENTS:
  EXHIBIT 23.1
    CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
  EXHIBIT 31.1
    CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE ...
  EXHIBIT 31.2
    CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE ...
  EXHIBIT 32.1
    CERTIFICATION FURNISHED PURSUANT TO 18 U.S.C. SECTION 1350,
  EXHIBIT 32.2
    CERTIFICATION FURNISHED PURSUANT TO 18 U.S.C. SECTION 1350,